PINK vs. CNCR

Last updated Jun 24, 2026

PINK (Simplify Health Care ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. PINK is actively managed, while CNCR is passively managed. PINK charges 0.50%/yr vs 0.79%/yr for CNCR.

Performance

PINK vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Simplify Health Care ETF (PINK) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

PINK

• 1D: 0.59%
• 1M: 2.14%
• YTD: 3.02%
• 6M: 2.13%
• 1Y: 28.62%
• 3Y*: 13.33%
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PINK vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
PINK Simplify Health Care ETF	7.58%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

PINK vs. CNCR - Sectors Allocation Comparison

Sectors	PINK	CNCR
Healthcare	89.5%	96.6%
Industrials	10.5%	-
Financial Services	0.0%	3.3%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

PINK vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PINK

PINK Risk / Return Rank: 42
PINK Sharpe Ratio Rank: 48
PINK Sortino Ratio Rank: 49
PINK Omega Ratio Rank: 43
PINK Calmar Ratio Rank: 36
PINK Martin Ratio Rank: 36

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PINK vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Simplify Health Care ETF (PINK) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PINK	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	1.55	—	—
Sortino ratio: Return per unit of downside risk	2.27	—	—
Omega ratio: Gain probability vs. loss probability	1.26	—	—
Calmar ratio: Return relative to maximum drawdown	1.71	—	—
Martin ratio: Return relative to average drawdown	5.11	—	—

Drawdowns

PINK vs. CNCR - Drawdown Comparison

The maximum PINK drawdown since its inception was -18.77%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for PINK and CNCR.

Drawdown Indicators

	PINK	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-18.77%	0.00%	-18.77%
Max Drawdown (1Y) Largest decline over 1 year	-16.81%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-18.77%	—	—
Current Drawdown Current decline from peak	-2.24%	0.00%	-2.24%
Average Drawdown Average peak-to-trough decline	-6.71%	0.00%	-6.71%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.62%	—	—

Volatility

Volatility by Period

	PINK	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.50%	—	—
Volatility (6M) Calculated over the trailing 6-month period	13.83%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	18.53%	0.00%	+18.53%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.59%	0.00%	+17.59%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.59%	0.00%	+17.59%

PINK vs. CNCR - Expense Ratio Comparison

PINK has a 0.50% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

PINK vs. CNCR - Dividend Comparison

PINK's dividend yield for the trailing twelve months is around 0.66%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PINK Simplify Health Care ETF	0.66%	0.68%	0.32%	0.94%	0.42%	0.04%

Frequently Asked Questions

Which ETF is better, PINK or CNCR?

On fees, PINK is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, PINK or CNCR?

PINK is cheaper with a 0.50% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, PINK or CNCR?

PINK has the higher dividend yield at 0.66%, compared with 0.00% for CNCR.

What is the main difference between PINK and CNCR?

They also come from different issuers: Simplify and Exchange Traded Concepts. Their fees differ too: 0.50% for PINK and 0.79% for CNCR.